Lantheus Holdings (LNTH) Gains from Investment Securities (2020 - 2024)

Lantheus Holdings' (LNTH) quarterly Gains from Investment Securities came in at -$1.3 million in Q4 2024, down 747.0% year-on-year from $200000.0 in Q1 2024, and down 1394.0% on a QoQ basis from $100000.0 in Q2 2024.

Lantheus Holdings (LNTH) Gains from Investment Securities (2020 - 2024) Analysis & Trends

Lantheus Holdings (LNTH) has 5 years of Gains from Investment Securities data on file, last reported at -$1.3 million in Q4 2024.

  • On a quarterly basis, Gains from Investment Securities fell 747.0% year-over-year to -$1.3 million in Q4 2024; TTM through Dec 2024 was -$994000.0, a 89.28% increase from a year earlier, with the FY2024 full-year figure at -$2.7 million, up 70.9% from the prior year.
  • Gains from Investment Securities for Q4 2024 stood at -$1.3 million, down from $100000.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for LNTH reached as high as $43.9 million in Q4 2021 and fell as low as -$7.6 million in Q2 2023.
  • Historically, Gains from Investment Securities has averaged $5.9 million across 5 years, with a median of $250000.0 in 2021.
  • Across the five-year window, Gains from Investment Securities surged 6033.33% in 2022 and tumbled 747.0% in 2024, its largest moves.
  • Year by year, Gains from Investment Securities stood at -$2.8 million in 2020, then jumped by 1667.86% to $43.9 million in 2021, then plunged by 78.82% to $9.3 million in 2022, then sank by 97.85% to $200000.0 in 2023, then plunged by 747.0% to -$1.3 million in 2024.
  • Per Business Quant data, the three most recent Gains from Investment Securities figures were -$1.3 million in Q4 2024, $100000.0 in Q2 2024, and $200000.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.28 Bn 87.42 Bn -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn
10 Lantheus Holdings 7.04 Bn 6.54 Bn 230.92 Mn

Historic Data

Download Data
DateValue
Dec 31, 2024 -1.29 Mn
Dec 31, 2024 -1.29 Mn
Jun 30, 2024 100,000.00
Jun 30, 2024 100,000.00
Dec 31, 2023 200,000.00
Dec 31, 2023 200,000.00
Sep 30, 2023 -500,000.00
Sep 30, 2023 -500,000.00
Jun 30, 2023 -7.58 Mn
Jun 30, 2023 -7.58 Mn
Mar 31, 2023 -1.40 Mn
Mar 31, 2023 -1.40 Mn
Dec 31, 2022 9.30 Mn
Dec 31, 2022 9.30 Mn
Sep 30, 2022 -1.50 Mn
Sep 30, 2022 -1.50 Mn
Jun 30, 2022 8.50 Mn
Jun 30, 2022 8.50 Mn
Mar 31, 2022 18.40 Mn
Mar 31, 2022 18.40 Mn